Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The N-methyl-D-aspartate receptor 3A subunit (GluN3A) is a component of NMDA receptors, which are ionotropic glutamate receptors mediating excitatory neurotransmission. Unlike canonical NMDA receptors, GluN1-GluN3 receptors are activated solely by glycine. They exhibit reduced single-channel conductance, low calcium permeability, and low voltage-dependent sensitivity to magnesium block. GluN3A plays specialized roles in neuronal signaling distinct from typical synaptic plasticity functions, including regulation of neuronal excitability, modulation of circuit function, involvement in dendritic spine development, and participation in PPP2CB-NMDAR mediated signaling pathways.
Glycine-gated ion channel modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-methyl-D-aspartate Receptor 3A Subunit (GluN3A).